Ireland
--:--IST
Active, not recruiting Not applicable

Drain Removal Before Versus After CPM in Primary Total Knee Arthroplasty

NCT07302724 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-06-15
Last updated
2025-12-24

Condition(s) studied

Knee Osteoarthritis (Knee OA)Total Knee AnthroplastyPostoperative Hematoma

Investigational drug(s) / intervention(s)

Drain Removal Before CPMDrain Removal After CPM

Drain Removal Before CPM: Hemovac drain removal performed approximately 24 hours after primary TKA, immediately before a standardized 1-hour CPM session (0-90°). All other surgical, perioperative, and rehabilitation protocols are identical across study arms.

Drain Removal After CPM: A standardized 1-hour CPM session at 0-90° is administered approximately 24 hours after primary TKA. The hemovac drain is removed immediately after completion of the CPM session. All other surgical, perioperative, and rehabilitation protocols are identical across study arms.

Study summary

The aim of this prospective randomized controlled study was to determine whether the timing of drain removal in relation to continuous passive motion (CPM) application influences postoperative residual hematoma formation following primary total knee arthroplasty (TKA). Our primary hypothesis was that removing the drain after initiating CPM would result in less residual hematoma, as CPM-induced intra-articular fluid and blood mobilization would be evacuated through the drain before its removal, thereby reducing postoperative fluid accumulation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older * Undergoing primary unilateral total knee arthroplasty (TKA) for end-stage knee osteoarthritis * Able to provide written informed consent * Able to comply with scheduled postoperative follow-up assessments Exclusion Criteria: * Revision total knee arthroplasty * Previous infection in the index knee * Inflammatory arthropathy * Neuromuscular disorders affecting lower extremity function * Inability to attend follow-up visits

Primary outcome measure(s)

  • Residual Hematoma Formation — Preoperative; Postoperative Day 2; Day 14; Day 28
    Residual hematoma formation assessed by knee circumference measurements at the level of the superior pole of the patella. Circumference is measured on both the operated and contralateral knees. The difference from baseline and between-group differences are evaluated.

Trial sites (1)

FacilityCityRegionStatus
Ankara Etlik City Hospital Ankara Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07302724 on ClinicalTrials.gov ↗ ← All trials in Turkey